• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

The Cannabidiol Early Psychosis Project: A Randomised Controlled Trial

Grant number: TP827709 | Funding period: 2020 - 2027

Active

Related publications (2)

Scholarly works icon

Perceived stigma and self-stigma in young people at ultra-high risk for psychosis: Associations with identity-related, psychological and functional outcomes

Z Waters, JL Ohan, Y Perry, S Baird, J Kean, P Amminger, R Street, A Lin

2025-10-01

Background and hypothesis: Perceived stigma and self-stigma negatively affect identity-related, psychological and functional outco..

Scholarly works icon

Cannabidiol for at risk for psychosis youth: A randomized controlled trial

GP Amminger, A Lin, M Kerr, A Weller, J Spark, C Pugh, S O'Callaghan, M Berger, SR Clark, JG Scott, A Baker, I McGregor, D Cotter, Z Sarnyai, A Thompson, AR Yung, B O'Donoghue, E Killackey, C Mihalopoulos, HP Yuen

2022-04-01

Background: No biological treatment has been firmly established for the at-risk stage of psychotic disorder. In this study we aim ..

University of Melbourne Researchers

Paul Amminger's Profile Picture
Paul Amminger

Patrick McGorry's Profile Picture
Patrick McGorry

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224